Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine plus betahistine for primary tinnitus with insomnia
IRCT20190427043389N4Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in primary tinnitus and Insomnia comparing Betahistine + memantine with Betahistine + placebo (2 arms). Primary endpoints: Severity of insomnia, Quality of life and 1 more. Started Aug 2023; status: completed.
02
Drugs
memantinebetahistine
03
Conditions
primary tinnitusInsomnia
Beyond the preview
Go deeper on IRCT20190427043389N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190427043389N4.